Valuation : IOL Chemicals and Pharmaceuticals Limited

Market Cap 54.61B 573M 491M 461M 421M 795M 799M 5.46B 2.12B 27.55B 2.15B 2.1B 91.25B P/E 2027 *
24.8x
P/E 2028 * 19.2x
Enterprise Value 54.61B 573M 491M 461M 421M 795M 799M 5.46B 2.12B 27.55B 2.15B 2.1B 91.25B EV / Sales 2027 *
1.99x
EV / Sales 2028 * 1.73x
Free-Float
33.91%
Yield 2027 *
-
Yield 2028 * -
1 day+0.03%
1 week+18.54%
Current month+27.29%
1 month+22.68%
3 months+36.82%
6 months+151.76%
Current year+126.26%
1 week 158
Extreme 158
191.5
1 month 143.55
Extreme 143.55
191.5
Current year 67.14
Extreme 67.14
191.5
1 year 67.14
Extreme 67.14
191.5
3 years 57.51
Extreme 57.51
191.5
5 years 54.44
Extreme 54.44
191.5
10 years 8.4
Extreme 8.4
191.5
Manager TitleAgeSince
Chief Executive Officer 34 -
Director of Finance/CFO - -
Compliance Officer - 13/11/2019
Director TitleAgeSince
Chairman 63 31/08/2007
Director/Board Member 34 28/05/2015
Chairman 73 -
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+18.54%+102.83%+142.29% 573M
-3.59%-7.10%+61.60%+114.83% 1,060B
-1.15%-1.25%+52.98%+62.41% 651B
-1.09%-1.15%+26.18%+79.22% 465B
-0.76%+0.24%+42.09%+42.09% 365B
-0.76%+0.05%+25.57%+41.75% 300B
-0.15%+1.53%+3.05%+13.24% 258B
-0.43%-0.46%+52.06%+71.75% 238B
-1.39%+1.84%-13.11%-52.28% 210B
-0.46%+0.33%+29.05%+92.67% 184B
Average -0.98%+1.25%+38.23%+60.80% 373.1B
Weighted average by Cap. -1.63%-2.15%+40.42%+67.99%

Financials

2027 *2028 *
Net sales 27.42B 288M 247M 232M 212M 399M 401M 2.74B 1.06B 13.84B 1.08B 1.06B 45.82B 31.52B 331M 284M 266M 243M 459M 461M 3.15B 1.22B 15.9B 1.24B 1.21B 52.68B
Net income 2.2B 23.05M 19.78M 18.57M 16.96M 32M 32.15M 220M 85.14M 1.11B 86.53M 84.65M 3.67B 2.84B 29.78M 25.56M 23.99M 21.91M 41.35M 41.55M 284M 110M 1.43B 112M 109M 4.75B
Net Debt - -
Logo IOL Chemicals and Pharmaceuticals Limited
IOL Chemicals and Pharmaceuticals Limited is engaged in manufacturing and selling of pharmaceutical and chemical products. The Company operates through two segments: Chemical and Pharmaceutical. The Chemical segment produces and sells Ethyl Acetate, Iso Butyl Benzene, Acetyl Chloride, Mono Chloro Acetic Acid, Para Amino Phenol (PAP), and others. The Pharmaceutical segment produces and sells various active pharma ingredients (API) including Ibuprofen, Metformin, Fenofibrate, Lamotrigine, Clopidogrel Bisulphate, Pantoprazole, Gabapentin, Paracetamol, and others. Its API product portfolio includes Pantoprazole Sodium, Clopidogrel Bisulphate (Form II), Losartan Potassium, Levetiracetam, and Fenofibrate (Micronised). Its Specialty Chemical division includes Ethyl Acetate, Iso Butyl Benzene, Mono Chloro acetic Acid, and Acetic Anhydride. Its Ethyl Acetate is used in industries like flexible packaging, pharmaceuticals, ink, food processing, pesticides, and the paint industry.
Employees
3,095
Date Price Change Volume
27/08/26 186.05 0.00% 376,362
26/08/26 ₹186.05 +7.89% 904,029
25/08/26 ₹172.45 +1.92% 285,009
24/08/26 ₹169.20 -0.21% 291,080
21/08/26 ₹169.55 +3.51% 435,008
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
186.05INR
Average target price
197.00INR
Spread / Average Target
+5.89%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IOLCP Stock